Arcus Biosciences, Inc. (RCUS)
NYSE · Common · CUSIP 03969F109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RCUS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
03969F109
Market Cap
Large Cap
IPO
$15.00/share
Business: Arcus Biosciences, Inc.is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. Arcus is expediting the development of first- or best-in-class medicines against well characterized biology and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer.

Company Contact

CEO
Terry Rosen, Ph.D.
CFO
Bob Goeltz
Headquarters
3928 Point Eden Way, Hayward, CA 94545
Phone
510-694-6200 · Toll-Free 800-227-0845
Investor Relations
Holli Kolkey · 650-922-1269 · hkolkey@arcusbio.com
General Email
investorinfo@arcusbio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »